Conference Coverage

PSYCHIATRY UPDATE 2016


 

Comorbidity of Schizophrenia and Substance Abuse
Henry A. Nasrallah, MD, Saint Louis University

Approximately one-half of patients with schizophrenia have comorbid substance abuse, including nicotine, alcohol, Cannabis, and other substances, a rate that is approximately 3 times higher than in the general population. Drugs of abuse that directly increase dopamine transmission in the nucleus accumbens produce a “high” as well as psychotic symptoms. Clozapine, although usually used only for refractory patients, might be helpful in reducing substance abuse; case reports include alcohol, cocaine, nicotine, and polydrug use. Risperidone may be helpful, but only 12% of drug abusing patients taking risperidone achieved abstinence compared with 54% with clozapine. Naltrexone has evidence of efficacy for alcohol abuse. Evidence is mixed or insufficient for olanzapine, ziprasidone, aripiprazole, and anticonvulsants.

Pages

Recommended Reading

FDA announces new plan to combat opioid abuse
MDedge Psychiatry
NIDA releases strategic plan to prevent, treat substance use disorders
MDedge Psychiatry
ThriveNYC could help treat and destigmatize mental, behavioral disorders
MDedge Psychiatry
Designer drug symptoms can mimic schizophrenia, anxiety, depression
MDedge Psychiatry
Opioid prescribing: An odyssey of challenges
MDedge Psychiatry
Opiate drug detox appears safe in pregnancy
MDedge Psychiatry
Pot tied to increased risk of substance use disorders, not depression or anxiety
MDedge Psychiatry
We are not ‘psychiatrists’; 'The beauty of the asylum’; Challenges with false-positive urine drug screens
MDedge Psychiatry
Marijuana tourists also visiting Colorado EDs
MDedge Psychiatry
VIDEO: How proposed patient substance use privacy rule impacts physicians
MDedge Psychiatry